Tu1711 – Extended Treatment with Mirikizumab in Patients with Moderately-To-Severely Active Ulcerative Colitis: Results from a Phase 2 Trial
Sandborn, William J., Ferrante, Marc, Bhandari, Bal R., Berliba, Elina, Hibi, Toshifumi, D'Haens, Geert R., Tuttle, Jay, Krueger, Kathryn A., Friedrich, Stuart, Durante, Michael, Arora, Vipin, Feagan,Volume:
156
Language:
english
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(19)39697-0
Date:
May, 2019
File:
PDF, 606 KB
english, 2019